Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $4.7M | $4.2M | $19.7M | $0 |
| Cost of revenue | $0 | $0 | $0 | $2.1M | $262.0K | $232.0K | $0 |
| Gross profit | $0 | $0 | $0 | $2.6M | $3.9M | $19.5M | $0 |
| Gross margin | — | — | — | 55.3% | 93.7% | 98.8% | — |
| R&D | $10.7M | $0 | $22.5M | $24.0M | $25.0M | $40.1M | $21.0M |
| Operating income | −$14.1M | −$20.8M | −$28.2M | −$28.3M | −$28.8M | −$30.4M | −$31.2M |
| EBITDA | −$14.1M | −$20.8M | −$26.7M | −$27.4M | −$27.6M | −$29.3M | −$30.1M |
| Net income | −$14.0M | −$20.8M | −$28.0M | −$27.3M | −$27.6M | −$31.2M | −$33.2M |
| Net margin | — | — | — | -576.7% | -662.8% | -158.3% | — |
| EPS (diluted) | -16.67 | -24.27 | -30.73 | -26.84 | -2.93 | -1.65 | -1.21 |
Annual figures · source: Financial Modeling Prep
ARYX THERAPEUTICS INC
No one on the platform currently holds ARYX.
No tracked institution reports a position in ARYX as of their last filing.
No one on the platform has traded ARYX yet.
| +0.00% |
| $43451 |
| — |
| ONSSOnassis Holdings Corp. | $0.00 | +49.25% | $3926 | — |
| OWCPOWC Pharmaceutical Research Corp. | $0.00 | +0.00% | $4975 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ARYX had the Zabacus Low score for 3/11 of 203 stocks evaluated Z~Score of 1.5 Buy Area
View on StockTwits ↗Time to buy $ARYX is now as it took its profit drop for the day will be up high in am only down on minor neg new about not doing merger
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.